Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Financing channel feed
Gene therapy developer Orchard prices IPO at $14 to raise $200M
7 years ago
Cell/Gene Tx
Finally! Innovent hikes on Hong Kong debut amid cloudy market sentiments
7 years ago
China
WuXi dives into computational drug discovery, launches New York-based JV with Schrödinger
7 years ago
China
AI
Arch Venture sets its sights on raising $600M for Fund X
7 years ago
Pharma
Terns scores $80M in Series B financing led by Vivo, OrbiMed
7 years ago
China
Julian Adams manages to complete his $50M IPO at Gamida Cell — at a heavy cost
7 years ago
Carving a pipeline out of troubled Teva, OrbiMed leads $60M launch of new NASH player
7 years ago
Startups
Novo-backed Galecto Biotech scores €79 million in Series C funding
7 years ago
Milestone Pharma grabs an $80M round as it steams into pivotal trial work, starts outlining commercial structure
7 years ago
Startups
Hong Kong IPO delivers $421M to Innovent as another one of China's biotech unicorns hauls in big money
7 years ago
China
Bain’s Adam Koppel commits $350M to launching a new biotech that is carving out Pfizer’s neuro pipeline
7 years ago
Startups
In key endorsement, Deerfield reserves $65M for drug venture with UNC-Chapel Hill
7 years ago
Medicines Co execs grab a $33M A round to spin out an infectious disease outfit with a pipeline
7 years ago
Startups
Fidelity, Valor pool $71.8M for Jeff Aronin's plan to reformulate a generic for butterfly skin disease at Castle Creek Pharma
7 years ago
TP Therapeutics grabs $80M mezzanine round to fund a pivotal trial for ROS-1/NTRK-positive cancers
7 years ago
Biotech vets launch a neuro startup with $54.5M to kickstart R&D
7 years ago
Startups
Six years after a spectacular debut, Warp Drive Bio is powering down and handing its 'undruggable' ambitions over to Revolution
7 years ago
Taiho antes up an extra $250M for its venture arm as it gets serious about 'global oncology' deals
7 years ago
Innovent to seek $400M-plus on Hong Kong IPO, reports say; will it revive biotech's fortunes on HKEX?
7 years ago
China
Arie Belldegrun and David Chang score record IPO, now they plan to win the race to a historic FDA OK
7 years ago
Versant-backed Gotham Therapeutics launches with $54M round and a new way to connect on mRNA
7 years ago
Startups
MIT spinout from Sangeeta Bhatia’s lab gets a $22M round to develop new disease and drug sensors
7 years ago
Startups
5AM partners set a wakeup call for biotech Fund VI, shooting for a record $350M
7 years ago
GSK hands cash and tech to a biotech startup pointed down the same R&D road they want to travel
7 years ago
Startups
First page
Previous page
121
122
123
124
125
126
127
Next page
Last page